We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Factors determining the choice between subcutaneous or transvenous implantable cardioverter-defibrillators in Poland in comparison with other European countries: a sub-study of the European Heart Rhythm Association prospective survey.
- Authors
Jędrzejczyk-Patej, Ewa; Boveda, Serge; Kalarus, Zbigniew; Mazurek, Michał; Gościńska-Bis, Kinga; Kiliszek, Marek; Przybylski, Andrzej; Potpara, Tatjana S.; Tilz, Roland; Fumagalli, Stefano; Dagres, Nikolaos; Lenarczyk, Radosław
- Abstract
Background: Subcutaneous implantable cardioverter-defibrillator (S-ICD) may be an alternative to transvenous ICD (TV-ICD). Aim: We sought to evaluate factors determining the choice of S-ICD vs. TV-ICD in Polish patients in comparison to other European countries. Methods: All consecutive patients who underwent TV-ICD or S-ICD implantation in centres participating in the European Heart Rhythm Association prospective snapshot survey were included. Results: During an eight-week study period, 429 patients were recruited, including 136 (31.7%) ICD patients from Poland (eight with S-ICD). In comparison to other European centres, the proportion of S-ICD implantations in Poland was lower (7% vs. 26%, p < 0.001), whereas the ratio of cardiac resynchronisation therapy defibrillator implantations was higher (43% vs. 26%; p < 0.001). Subjects receiving S-ICD in Poland were more often over 75 years old (25% vs. 0%, p < 0.001), in New York Heart Association class II (87.5% vs. 29.4%, p = 0.001), with chronic kidney disease (37.5% vs. 5.9%, p = 0.003), and with lower left ventricular ejection fraction (32% [14%--50%] vs. 50% [25%--60%], p = 0.04), compared to other European countries. Additionally, in comparison to subjects from other European centres, Polish patients were significantly more often implanted with S-ICD due to prior infection (37.5% vs. 1.5%, p < 0.001) and a lack of venous access (25% vs. 0%, p < 0.001), whereas the largest subset of patients in other European countries were implanted with S-ICD because of young age (50% vs. 25%, p = NS). Conclusions: The main reasons leading to S-ICD implantations in Polish patients differ from the indications adopted in other European countries. In Poland, patients referred for TV-ICD or S-ICD implantation had more advanced heart failure and more comorbidities in comparison to subjects from other European countries. S-ICD is still underused in Polish patients.
- Subjects
EUROPE; POLAND; CARDIAC pacing; CHRONIC kidney failure; HEART failure; IMPLANTABLE cardioverter-defibrillators; LONGITUDINAL method; SURVEYS; DECISION making in clinical medicine; COMORBIDITY; NORTH American Society of Pacing &; Electrophysiology; VENTRICULAR ejection fraction
- Publication
Polish Heart Journal / Kardiologia Polska, 2018, Vol 76, Issue 11, p1507
- ISSN
0022-9032
- Publication type
Article
- DOI
10.5603/KP.a2018.0155